New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 1, 2019 - US WorldMeds announced the FDA approval of Zelnorm (tegaserod), for the treatment of adult women less than 65 years of age with irritable bowel syndrome with constipation (IBS-C).
Download PDF
Return to publications
